189 related articles for article (PubMed ID: 31901438)
1. Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Zaman S; Hajiran A; Coba GA; Robinson T; Madanayake TW; Segarra DT; Chobrutskiy BI; Boyle TA; Zhou JM; Kim Y; Mulé JJ; Teer JK; Manley BJ
Eur Urol Focus; 2021 Mar; 7(2):373-380. PubMed ID: 31901438
[TBL] [Abstract][Full Text] [Related]
2. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
3. Proteogenomic, Epigenetic, and Clinical Implications of Recurrent Aberrant Splice Variants in Clear Cell Renal Cell Carcinoma.
Chang A; Chakiryan NH; Du D; Stewart PA; Zhang Y; Tian Y; Soupir AC; Bowers K; Fang B; Morganti A; Teer JK; Kim Y; Spiess PE; Chahoud J; Noble JD; Putney RM; Berglund AE; Robinson TJ; Koomen JM; Wang L; Manley BJ
Eur Urol; 2022 Oct; 82(4):354-362. PubMed ID: 35718636
[TBL] [Abstract][Full Text] [Related]
4. Next-generation sequencing of translocation renal cell carcinoma reveals novel RNA splicing partners and frequent mutations of chromatin-remodeling genes.
Malouf GG; Su X; Yao H; Gao J; Xiong L; He Q; Compérat E; Couturier J; Molinié V; Escudier B; Camparo P; Doss DJ; Thompson EJ; Khayat D; Wood CG; Yu W; Teh BT; Weinstein J; Tannir NM
Clin Cancer Res; 2014 Aug; 20(15):4129-40. PubMed ID: 24899691
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion.
Fu Q; Xu L; Wang Y; Jiang Q; Liu Z; Zhang J; Zhou Q; Zeng H; Tong S; Wang T; Qi Y; Hu B; Fu H; Xie H; Zhou L; Chang Y; Zhu Y; Dai B; Zhang W; Xu J
Eur Urol; 2019 May; 75(5):752-763. PubMed ID: 30293904
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of immunohistochemical staining for myoferlin in clear cell renal cell carcinoma and its association with epidermal growth factor receptor expression.
Jung M; Lee C; Park JH; Moon KC
Urol Oncol; 2019 Nov; 37(11):812.e9-812.e16. PubMed ID: 31421995
[TBL] [Abstract][Full Text] [Related]
7. EGFR expression is linked to osteopontin and Nf-κB signaling in clear cell renal cell carcinoma.
Matušan-Ilijaš K; Damante G; Fabbro D; Dorđević G; Hadžisejdić I; Grahovac M; Avirović M; Grahovac B; Jonjić N; Lučin K
Clin Transl Oncol; 2013 Jan; 15(1):65-71. PubMed ID: 22855173
[TBL] [Abstract][Full Text] [Related]
8. Transcriptomic signatures related to the obesity paradox in patients with clear cell renal cell carcinoma: a cohort study.
Sanchez A; Furberg H; Kuo F; Vuong L; Ged Y; Patil S; Ostrovnaya I; Petruzella S; Reising A; Patel P; Mano R; Coleman J; Russo P; Liu CH; Dannenberg AJ; Chan TA; Motzer R; Voss MH; Hakimi AA
Lancet Oncol; 2020 Feb; 21(2):283-293. PubMed ID: 31870811
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of FABP7 promotes cell growth and predicts poor prognosis of clear cell renal cell carcinoma.
Zhou J; Deng Z; Chen Y; Gao Y; Wu D; Zhu G; Li L; Song W; Wang X; Wu K; He D
Urol Oncol; 2015 Mar; 33(3):113.e9-17. PubMed ID: 25192834
[TBL] [Abstract][Full Text] [Related]
10. A novel molecular signature identifies mixed subtypes in renal cell carcinoma with poor prognosis and independent response to immunotherapy.
Büttner FA; Winter S; Stühler V; Rausch S; Hennenlotter J; Füssel S; Zastrow S; Meinhardt M; Toma M; Jerónimo C; Henrique R; Miranda-Gonçalves V; Kröger N; Ribback S; Hartmann A; Agaimy A; Stöhr C; Polifka I; Fend F; Scharpf M; Comperat E; Wasinger G; Moch H; Stenzl A; Gerlinger M; Bedke J; Schwab M; Schaeffeler E
Genome Med; 2022 Sep; 14(1):105. PubMed ID: 36109798
[TBL] [Abstract][Full Text] [Related]
11. The Arkadia-ESRP2 axis suppresses tumor progression: analyses in clear-cell renal cell carcinoma.
Mizutani A; Koinuma D; Seimiya H; Miyazono K
Oncogene; 2016 Jul; 35(27):3514-23. PubMed ID: 26522722
[TBL] [Abstract][Full Text] [Related]
12. Gene expression pattern of the epidermal growth factor receptor family and LRIG1 in renal cell carcinoma.
Thomasson M; Hedman H; Ljungberg B; Henriksson R
BMC Res Notes; 2012 May; 5():216. PubMed ID: 22554477
[TBL] [Abstract][Full Text] [Related]
13. EGFR protein overexpression correlates with chromosome 7 polysomy and poor prognostic parameters in clear cell renal cell carcinoma.
Dorđević G; Matušan Ilijaš K; Hadžisejdić I; Maričić A; Grahovac B; Jonjić N
J Biomed Sci; 2012 Apr; 19(1):40. PubMed ID: 22475688
[TBL] [Abstract][Full Text] [Related]
14. MFN2 suppresses clear cell renal cell carcinoma progression by modulating mitochondria-dependent dephosphorylation of EGFR.
Luo L; Wei D; Pan Y; Wang QX; Feng JX; Yu B; Kang T; Luo J; Yang J; Gao S
Cancer Commun (Lond); 2023 Jul; 43(7):808-833. PubMed ID: 37378422
[TBL] [Abstract][Full Text] [Related]
15. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.
Minner S; Rump D; Tennstedt P; Simon R; Burandt E; Terracciano L; Moch H; Wilczak W; Bokemeyer C; Fisch M; Sauter G; Eichelberg C
Cancer; 2012 Mar; 118(5):1268-75. PubMed ID: 22161775
[TBL] [Abstract][Full Text] [Related]
16. DYSF expression in clear cell renal cell carcinoma: A retrospective study of 2 independent cohorts.
Ha M; Jeong H; Roh JS; Lee B; Han ME; Oh SO; Sohn DH; Kim YH
Urol Oncol; 2019 Oct; 37(10):735-741. PubMed ID: 31377166
[TBL] [Abstract][Full Text] [Related]
17. LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis.
Thomasson M; Hedman H; Guo D; Ljungberg B; Henriksson R
Br J Cancer; 2003 Oct; 89(7):1285-9. PubMed ID: 14520461
[TBL] [Abstract][Full Text] [Related]
18. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
[TBL] [Abstract][Full Text] [Related]
19. Prognostic Impact of Membranous/Nuclear Epidermal Growth Factor Receptor Localization in Clear Cell Renal Cell Carcinoma.
Muroni MR; Ribback S; Sotgiu G; Kroeger N; Saderi L; Angius A; Cossu-Rocca P; De Miglio MR
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445451
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of placenta specific 8 is associated with malignant progression and poor prognosis of clear cell renal cell carcinoma.
Shi L; Xiao L; Heng B; Mo S; Chen W; Su Z
Int Urol Nephrol; 2017 Jul; 49(7):1165-1176. PubMed ID: 28349447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
